Cannabis Global Provides Patent Applications Update - Company Files Response to US Patent Office Relative to Cannabis Nanoparticle Application

Rhea-AI Summary

Cannabis Global (OTC PINK:CBGL) has announced updates regarding its patent applications for cannabis technologies, especially concerning cannabinoid nanoparticles and cannabosides. The company is pursuing two non-provisional patent applications for production methods of nanoparticles, aimed at enhancing cannabinoid dosing in products like pharmaceuticals and edibles. Additionally, Cannabis Global filed for international protection under the PCT for these inventions. The updates reflect ongoing efforts to strengthen its intellectual property in the cannabis sector.

Positive

• Pursuing two non-provisional patent applications for cannabinoid technologies.
• Patent application for nanoparticles aims at improved cannabinoid dosing in various products.
• International patent protection under PCT for both categories of inventions.

Negative

• Company owns no issued patents yet, highlighting reliance on pending applications.

LOS ANGELES, CA / ACCESSWIRE / August 16, 2022 / Cannabis Global, Inc. (OTC PINK:CBGL), Cannabis Global, Inc., a licensed Los Angeles-based manufacturer and distributor in the cannabis sector, today provides an update concerning the Company's patent applications, especially relating to its application to protect inventions and processes for unique cannabis nanoparticles.

Cannabis Global continues to pursue two non-provisional patent applications for cannabis technologies. The first of these relates to the use of state-of-the-art production devices to produce nanoparticles and nanofibers made from cannabinoids. These tiny "pieces" of cannabinoids are only between 100 nanometers and 700 nanometers wide, which is as small as less than 1% of the width of a human hair. Cannabis Global plans to use this technology to provide more efficient dosing of cannabinoids in a variety of new products, such as pharmaceuticals, food, beverages, and topical skin preparations. The non-provisional filing occurred on July 8, 2021 and is currently being reviewed by the U.S patent office. In addition, earlier this month, the Company responded to clarifications posed by the U.S. patent office relative to the priority the Company wished to be given to the several separate inventions within the application.

The Company's cannabinoid nanoparticle and nanofiber patent applications can be viewed at: https://uspto.report/patent/app/20210205224.

In addition, Cannabis Global has filed for protection for inventions relating to the creation of cannabosides, which are modifications of the naturally occurring, plant-based cannabinoids that could potentially significantly increase the bio-absorption of cannabis-related compounds by the human body. In the case of the Company's technology to create cannabosides, non-THC containing hemp or THC containing cannabis are fed to insects, which convert the cannabinoids within the feedstock into cannabosides. The Company filed the non-provisional patent on January 18, 2021. The Company's patent application relating to cannabosides can be viewed at https://patents.google.com/patent/WO2021146687A1/en.

Cannabis Global has also filed for international protection for both categories of these inventions from the International Patent Cooperation Union (PCT). The PCT assists applicants in seeking patent protection internationally for their inventions, helps patent offices with their patent granting decisions and facilitates public access to a wealth of technical information relating to those inventions. ​​By filing one international patent application under the PCT, applicants can simultaneously seek protection for an invention in numerous countries via a single application.

About Cannabis Global, Inc.

Cannabis Global, Inc. is a Los Angeles-based, fully audited and reporting Company with the U.S. Securities & Exchange Commission, trading under the stock symbol CBGL. We are an emerging force in the cannabis marketplace with a growing product and proprietary intellectual property portfolio. We are marketing and producing Comply Bag™, an innovative solution for cannabis storage, transport and tracking. Our subsidiary, Natural Plant Extract (NPE), is a Southern California licensed cannabis manufacturer and distributor which licenses our technologies to produce edibles for the cannabis marketplace. Cannabis Global has filed three non-provisional and multiple provisional patents for cannabis infusion and nanoparticle technologies and continues an active research & development program.

Forward-Looking Statements

This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Corporate contact:

Edward Manolos

IR@cannabisglobalinc.com

The Company owns no issued patents.

SOURCE: Cannabis Global, Inc.

View source version on accesswire.com:
https://www.accesswire.com/712258/Cannabis-Global-Provides-Patent-Applications-Update--Company-Files-Response-to-US-Patent-Office-Relative-to-Cannabis-Nanoparticle-Application

FAQ

What are the recent patent updates from Cannabis Global (CBGL)?

Cannabis Global is pursuing two non-provisional patent applications for cannabinoid nanoparticles and cannabosides, enhancing its intellectual property portfolio.

How does Cannabis Global plan to utilize its nanoparticle technology?

The company intends to use its nanoparticle technology to improve cannabinoid dosing in pharmaceuticals, food, beverages, and topical applications.

What is the significance of the PCT filing for Cannabis Global (CBGL)?

Filing under the PCT allows Cannabis Global to seek international patent protection for its inventions efficiently, expanding its potential market reach.

When were the non-provisional patent applications for Cannabis Global filed?

The non-provisional patent application for cannabinoid nanoparticles was filed on July 8, 2021, and for cannabosides on January 18, 2021.